Despite selling recently, Ajanta Pharma Limited insiders own 53 percent stake and recent decline might have cost them - Simply Wall St
AJANTPHARM | 3,027 30.05 1.00% |
Under 51% of Ajanta Pharma's investor base is interested to short. The analysis of overall sentiment of trading Ajanta Pharma Limited stock suggests that many investors are impartial at this time. Ajanta Pharma's investing sentiment shows overall attitude of investors towards Ajanta Pharma Limited.
Ajanta |
Despite selling recently, Ajanta Pharma Limited insiders own 53 percent stake and recent decline might have cost them Simply Wall St
Read at news.google.com
Ajanta Pharma Fundamental Analysis
We analyze Ajanta Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ajanta Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ajanta Pharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Ajanta Pharma is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Ajanta Pharma Limited Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ajanta Pharma stock to make a market-neutral strategy. Peer analysis of Ajanta Pharma could also be used in its relative valuation, which is a method of valuing Ajanta Pharma by comparing valuation metrics with similar companies.
Peers
Ajanta Pharma Related Equities
LTFOODS | LT Foods | 5.28 | ||||
SARVESHWAR | Sarveshwar Foods | 4.87 | ||||
FOODSIN | Foods Inns | 1.36 | ||||
ADFFOODS | ADF Foods | 0.94 | ||||
VERTOZ | Vertoz Advertising | 0.13 | ||||
KOHINOOR | Kohinoor Foods | 1.03 | ||||
MEDIASSIST | MEDI ASSIST | 2.87 |
Complementary Tools for Ajanta Stock analysis
When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |